2013 Provided Few Small-Molecule Decisions
For pharmaceutical patent practitioners, the 2012 ruling Otsuka Pharmaceutical Co. v. Sandoz further solidified the Federal Circuit's two-part test that it regularly applies when considering small-molecule pharmaceutical obviousness. Under the court's...To view the full article, register now.
Already a subscriber? Click here to view full article